Resource Archive · COVID-19 Archive
Archived resource. Preserved from the former Council website. For current standing orders, visit Regional Protocol.
Virtual Drug Bag
![]() |
![]() |
PACKAGED: 1:10,000—l mg/10ml (8 in drug bag) 10 ml prefilled syringe
1:1,000—30 ml vial, 1 mg/ml
Autoinjector: Adult 0.3 mg
Or JR. 0.15 mg
LOCATION: Main Compartment
INDICATIONS:
VF, pulseless VT, asystole, PEA
Asthma in severe distress
Anaphylaxis or allergic reaction in patients who remain hypotensive after fluid bolus
ADULT:
VF, pulseless VT, asystole and PEA:
1 mg IV 1:10,000
Asthma, anaphylaxis:
If ≥ 30 kg, give both Adult EpiPen and EpiPen Jr or Epi (1:1,000) 0.5 mg IM
- May repeat in 5 minutes
Allergic Reaction, Anaphylaxis in patients who remain hypotensive after fluid bolus: 0.5 mg of 1:10,000 slow IV.
PEDI:
VF, PULSELESS VT, Asystole and PEA, Bradycardia:
0.01 mg/kg of 1:10,000 IV; repeat every 3-5 min.
Asthma, Anaphylaxis:
Patient < 30 kg EpiPen Jr. (0.15 mg) or Epi (1:1,000) 0.01 mg/kg IM (max 0.5 mg)
- May be repeated in five minutes
THERAPEUTIC ACTION:
Directly stimulates alpha and beta adrenergic receptors in dose-related fashion; causes bronchodilation, vasoconstriction, and increased cardiac output.
CONTRAINDICATIONS:
PRECAUTIONS AND SIDE EFFECTS:
Headache, nausea, restlessness, weakness, dysrhythmias, including ventricular tachycardia and ventricular fibrillation, hypertension, precipitation of angina pectoris, tachycardia
May increase myocardial oxygen demand
Syncope has occurred following epinephrine administration to asthmatic children.
REQUIRES MCP:
ADULT: For arrest—No.
For repeat in asthmas, anaphylaxis –Yes
PEDI: For arrest—No
For repeat in asthmas, anaphylaxis —Yes


